Caratteristiche materne ed esiti perinatali associati allo screening del diabete gestazionale

  • Clarice dos Santos Mottecy Graduate Program in Health Promotion, University of Santa Cruz do Sul (UNISC), Santa Cruz do Sul-RS, Brazil.
  • Patrí­cia Molz Graduate Program in Health Promotion, University of Santa Cruz do Sul (UNISC), Santa Cruz do Sul-RS, Brazil; Experimental Nutrition Laboratory, University of Santa Cruz do Sul (UNISC), Santa Cruz do Sul-RS, Brazil; Graduate Program in Biomedical Sciences, Federal University of Health Sciences of Porto Alegre-RS (UFCSPA), Brazil.
  • Raquel Montagner Rossi Faculty of Medicine, Federal University of Santa Maria (UFSM), Santa Maria-RS, Brazil.
  • Itamar dos Santos Riesgo Department of Obstetrics and Gynaecology, Federal University of Santa Maria (UFSM), Santa Maria-RS, Brazil.
  • João Francisco Piovezan Ramos Federal University of Santa Maria (UFSM), Santa Maria-RS, Brazil.
  • Daniel Prá Graduate Program in Health Promotion, University of Santa Cruz do Sul (UNISC), Santa Cruz do Sul-RS, Brazil; Experimental Nutrition Laboratory, University of Santa Cruz do Sul (UNISC), Santa Cruz do Sul-RS, Brazil.
  • Silvia Isabel Rech Franke Graduate Program in Health Promotion, University of Santa Cruz do Sul (UNISC), Santa Cruz do Sul-RS, Brazil. 2 - Experimental Nutrition Laboratory, University of Santa Cruz do Sul (UNISC), Santa Cruz do Sul-RS, Brazil.
Parole chiave: Diabete gestazionale, Fattori di rischio, Assistenza prenatale, Salute materna e infantile

Abstract

Introduzione e obiettivo: il diabete gestazionale (GD) può portare a diversi esiti avversi per la madre e il feto. Pertanto, questo studio mira a descrivere i fattori di rischio e gli esiti nelle donne in gravidanza associati allo screening per la GD.Materiali e metodi: questo studio retrospettivo è stato condotto su 283 donne incinte presso un ospedale universitario nel sud del Brasile. I dati di screening della GD, inclusi i test della glicemia a digiuno e il test di tolleranza al glucosio orale (OGTT), sono stati raccolti dalla scheda della donna incinta. Sono state raccolte anche informazioni relative agli esiti materni e perinatali, nonché allo stato socioeconomico delle donne incinte.Risultati: Il tasso di screening positivo per GD nelle donne dopo il parto è stato del 25,2%, considerando solo la glicemia a digiuno. Tuttavia, è aumentato all’86,4% se si consideravano la glicemia a digiuno e la presenza di fattori di rischio. Non è stata riscontrata alcuna associazione significativa tra lo screening positivo per GD e gli esiti materni e perinatali, né con lo stato socioeconomico. Tuttavia, livelli di glucosio nel sangue a digiuno ≥ 85 mg/dl erano associati a un aumento del rischio di taglio cesareo e di altre complicanze fetali, come ipoglicemia, peso neonato inadeguato ed età gestazionale inferiore a 37 settimane alla nascita. Inoltre, lo screening della GD era significativamente associato all’esito della preeclampsia. Conclusione: i risultati dello studio indicano che lo screening positivo per la GD è associato ad un aumento del rischio di parto cesareo, preeclampsia e altre complicanze fetali.

Riferimenti bibliografici

-Babu, G.R.; Tejaswi, B.; Kalavathi, M.; Vatsala, G.M.; Murthy, G.V.S.; Kinra, S.; Neelon, S.E.B. Assessment of screening practices for gestational hyperglycaemia in public health facilities: a descriptive study in Bangalore, India. Journal of Public Health Research. Vol. 4. Num. 1. 2015. p. jphr-2015.

-Battaglia, F.C.; Lubchenco, L.O.A practical classification of newborn infants by weight and gestational age. The Journal of Pediatrics. Vol. 71. Num. 2. 1967. p.159-163.

-Brazil. Ministry of Health. Vigitel Brasil 2019: vigilance of risk factors and protection against chronic diseases through phone encounters: estimations on frequency and sociodemographic distribution of risk factors and protection against chronic diseases in the capitals of the 26 states and the Federal District in 2019. Brasília: Ministry of Health. 2020.

-Brazil. Ministry of Heath. Atenção ao pré-natal de baixo risco. Brasília: Ministry of Health. 2012.

-Brazilian Association of Research Companies. Brazilian Sociaty of Research Companies. Brasília: ABEP. 2013. www.abep.org/new/criterioBrasil.aspx.

-Brazilian Diabetes Society. Brazilian Diabetes Society Guideline 2019-2020. São Paulo. Clannad. 2019.

-Brazilian Society of Pediatrics. Guidelines of the Brazilian Society of Pediatrics. Neonatal hypoglycemia. Rio de Janeiro: Brazilian Society of Pediatrics. 2014.

-Capurro, H., Konichezky, S.; Fonseca, D.; Caldeyro-Barcia, R. A simplified method for diagnosis of gestational age in the newborn infant. The Journal of pediatrics. Vol. 93. Num. 1. 1978. p. 120-122.

-Detsch, J.C.M.; Almeida, A.C.R.D.; Bortolini, L.G.C.; Nascimento, D.J.; Junior, F.C.O.; Réa, R.R. Markers of diagnosis and treatment in 924 pregnancies with gestational diabetes mellitus. The Archives of Endocrinology and Metabolism. Vol. 55. Num. 6. 2011. p.389-398.

-Farahvar, S.; Walfisch, A.; Sheiner; E. Gestational diabetes risk factors and long-term consequences for both mother and offspring: a literature review. Expert Review of Endocrinology & Metabolism. Vol. 14. Num. 1. 2019. p. 63-74.

-Farrar, D.; Simmonds, M.; Bryant, M.; Lawlor, D.A.; Dunne, F.; Tuffnell, D.; Sheldon, T.A. Risk factor screening to identify women requiring oral glucose tolerance testing to diagnose gestational diabetes: a systematic review and meta-analysis and analysis of two pregnancy cohorts. PloS One. Vol. 12. Num. 4. 2017. p. e0175288.

-Hu, F. B. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care. Vol. 34. Num. 6. 2011. p. 1249-57.

-Institute of Medicine. Weight Gain During Pregnancy: Reexamining the Guidelines. Washington: National Academies Press. 2009.

-International Diabetes Federation. IDF Diabetes Atlas. 9th ed. Brussels: IDF. 2019.

-Logakodie, S.; Azahadi, O.; Fuziah, P.; Norizzati, B.I.B.; Tan, S.F.; Zienna, Z.Z.R.; Norliza, M.; Noraini, J.; Hazlin, M.; Noraliza, M. Z.; Sazidah, M. K. Gestational diabetes mellitus: The prevalence, associated factors and foeto-maternal outcome of women attending antenatal care. Malaysian Family Physician: The Official Journal of the Academy of Family Physicians of Malaysia. Vol. 12. Num. 2. 2017. p. 9.

-Mahalakshmi, M.M.; Bhavadharini, B.; Maheswari, K.; Kalaiyarasi, G.; Anjana, R.M.; Ranjit, U.; Mohan, V.; Joseph, K.; Rekha, K.; Nallaperumal, S.; Malanda, B. Comparison of maternal and fetal outcomes among Asian Indian pregnant women with or without gestational diabetes mellitus: a situational analysis study (WINGS-3). Indian Journal of Endocrinology and Metabolism. Vol. 20. Num. 4. 2016. p. 491.

-Massucatti, L.A.; Pereira, R.A.; Maioli, T.U. The prevalence of gestational diabetes in basic health units. Revista de Enfermagem e Atenção à Saúde. Vol. 1. Num. 01. 2012.

-Menezes, M.G.B.; Dias, D.F.S. A humanização do cuidado no pré-parto e parto. SynThesis Revista Digital FAPAM. Vol. 3. Num. 3. 2012. p. 24-36.

-Ng, R.; Sutradhar, R.; Yao, Z.; Wodchis, W.P.; Rosella, L. C. Smoking, drinking, diet and physical activity-modifiable lifestyle risk factors and their associations with age to first chronic disease. International Journal of Epidemiology. Vol. 49. Num. 1. 2020. p. 113-130.

-Pan-American Health Organization. Ministry of Health. Brazilian Federation of the Gynecology and Obstetrics Associations. Brazilian Society of Diabetes. Screening and diagnosis of gestational diabetes mellitus in Brazil. Brasília. OPAS. 2017.

-Sacks, D.A.; Hadden, D.R.; Maresh, M.; Deerochanawong, C.; Dyer, A.R.; Metzger, B.E.; Lowe, L.P.; Coustan, D.R.; Hod, M.; Oats, J.J.; Persson, B. Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes Care. Vol. 35. Num. 3. 2012. p. 526-528.

-Santos, P.A.; Madi, J.M.; Silva, E.R.; Vergani, D.D.; Araújo, B.F.; Garcia, R.M. Gestational diabetes in the population served by Brazilian public health care. Prevalence and risk factors. RBGO Gynecology and Obstetrics. Vol. 42. 2020. p. 12-8.

-Simon, C.Y.; Marques, M.C.; Farhat, H.L. First trimester fasting glycemia and risk factors of pregnant women diagnosed with gestational diabetes mellitus. RBGO Gynecology and Obstetrics. Vol. 35. 2013. p. 511-5.

-Spong, C.Y. Defining “term” pregnancy: recommendations from the Defining “Term” Pregnancy Workgroup. Jama. Vol. 309. Num. 23. p. 2445-6.

-World Health Organization. Global Report on Diabetes. Geneva: WHO. 2016.

-Yogev, Y.; Metzger, B.E.; Hod, M. April. Establishing diagnosis of gestational diabetes mellitus: Impact of the hyperglycemia and adverse pregnancy outcome study. Seminars in Fetal and Neonatal Medicine. Vol. 14. Num. 2, p. 94-100. 2009.

-Zhou, B.; Lu, Y.; Hajifathalian, K.; Bentham, J.; Di Cesare, M.; Danaei, G.; Bixby, H.; Cowan, M. J.; Ali, M.K.; Taddei, C.; Lo, W.C. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 44 million participants. The Lancet. Vol. 387. Num. 10027. 2016. p. 1513-1530.

Pubblicato
2024-08-06
Come citare
Mottecy, C. dos S., Molz, P., Rossi, R. M., Riesgo, I. dos S., Ramos, J. F. P., Prá, D., & Franke, S. I. R. (2024). Caratteristiche materne ed esiti perinatali associati allo screening del diabete gestazionale. Giornale Brasiliano Di obesità, Nutrizione E Perdita Di Peso, 18(115), 711-719. Recuperato da https://www.rbone.com.br/index.php/rbone/article/view/2459
Sezione
Articoli Scientifici - Original